The biggest drug distributor in the United States, McKesson Corp., has agreed to pay a combined $151 million to 29 states to settle claims that it inflated drug prices reported to state Medicaid programs. Prices provided to First Data Bank, whose index is used to determine drug pricing for those programs, were inflated by as much as 25%. California, which will receive a $23.5 million share of the settlement, reported the price-gouging went on from August 2001 to December 2009.
Featured News
Italian Ski-Pass Operators Agree to €30 Million Payout After Antitrust Probe
Aug 8, 2026 by
CPI
Delaware Court Orders Verisk to Pursue $2.35 Billion AccuLynx Deal Despite FTC Review
Aug 8, 2026 by
CPI
Trump Pushes Back on AI Rules as Congress Weighs Tighter Controls
Aug 8, 2026 by
CPI
Warren Raises Antitrust Concerns Over Private Home Listings
Aug 8, 2026 by
CPI
PlayStation Antitrust Cases Put Closed Console Stores Under Scrutiny
Aug 8, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Antitrust Compliance
Jul 20, 2026 by
CPI
Your Antitrust Compliance Program: A Strong Voice in Your Defense
Jul 20, 2026 by
Joe Murphy
Antitrust Compliance for the AI Pricing Era
Jul 20, 2026 by
Alejandra Uria & Andre Geverola
Race to Report: Antitrust Leniency in the Whistleblower Era
Jul 20, 2026 by
Brian R. Faerstein & Nicole H. Sprinzen
Antitrust-By-Design: Competition Compliance in Digital Markets
Jul 20, 2026 by
Marcos Drummond Malvar, Gabriela Costa Carvalho Forsman & Luciana Mendes